Our Pharma Insights Blog
Brazil is a huge pharmaceutical market that offers the pharmaceutical manufacturer fantastic potential. Registration of…
Drug development and drug approval process in Europe is subject to stringent laws and guidelines…
Novel and Innovative Drug Development involves several stakeholders and a talent pool from multiple and…
What Are Reference Listed Drugs (RLDs), and Why Do They Matter? A Reference Listed Drug…
Comparator drug sourcing plays a critical role in the clinical trial ecosystem. It involves identifying,…
Cell and gene therapy belong to the field of biomedical research and is currently categorized…
Clinical trials are the backbone of the drug development program and impact the success of…
Biological sample management refers to the methodical and organized processing, preservation, and disposal of products…
IPR is an abbreviation for Intellectual Property Rights that is legally bestowed upon innovators to…
A Reference Listed Drug (RLD) is the original, innovative, branded product that has been approved…
A Named Patient Program (NPP) is a unique access program that enables patients to get…
The process of obtaining a reference drug or comparator drug product for use in a…
